Robyn Emmins
Impact in
- Genetics top 5%
- Bacterial Genetics and Biotechnology
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in ⓘ
-
- Antibiotic Resistance in Bacteria 1
- Genetics 5
- Bacterial Genetics and Biotechnology 5
- Co-authors
- Richard A. Daniel (5 shared papers)Jeff Errington (4 shared papers)Leendert W. Hamoen (1 shared paper)Dennis Claessen (1 shared paper)D. H. Edwards (1 shared paper)Catriona Donovan (1 shared paper)Marc Bramkamp (1 shared paper)Louise Weston (1 shared paper)
- Journals
- Molecular Microbiology (4 papers)PDA Journal of Pharmaceutical Science and Technology (1 paper)The EMBO Journal (1 paper)Biotechnology Progress (1 paper)Clinical & Experimental Immunology (1 paper)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Robyn Emmins
8 papers receiving 622 citations
Peers
Comparison fields: 5 of 62
- Genetics 377
- Molecular Medicine 64
- Ecology 199
- Endocrinology 31
- Infectious Diseases 109
Countries citing papers authored by Robyn Emmins
This map shows the geographic impact of Robyn Emmins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn Emmins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn Emmins more than expected).
Fields of papers citing papers by Robyn Emmins
This network shows the impact of papers produced by Robyn Emmins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn Emmins. The network helps show where Robyn Emmins may publish in the future.
Co-authors
The 25 scholars most cited alongside Robyn Emmins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 201 | |
| 2 | 2008 | 173 | |
| 3 | 2008 | 135 | |
| 4 | 2010 | 55 | |
| 5 | 2015 | 33 | |
| 6 | 2017 | 26 | |
| 7 | 2024 | 3 | |
| 8 | 2019 | 2 |
About Robyn Emmins
Robyn Emmins is a scholar working on Molecular Medicine, Genetics, Ecology, Biotechnology and Molecular Biology, having authored 8 papers that have together received 628 indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (5 papers), RNA and protein synthesis mechanisms (3 papers), Bacteriophages and microbial interactions (3 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Genomics and Phylogenetic Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), CAR-T cell therapy research (1 paper) and Antibiotic Resistance in Bacteria (1 paper). The work is most often cited by research in Genetics (377 citations), Molecular Medicine (64 citations), Ecology (199 citations), Endocrinology (31 citations) and Infectious Diseases (109 citations). Robyn Emmins has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Richard A. Daniel, Jeff Errington, Leendert W. Hamoen, Dennis Claessen, D. H. Edwards, Catriona Donovan, Marc Bramkamp, Louise Weston, Jon Marles‐Wright and Masayoshi Kuwano. Their work appears in journals such as Molecular Microbiology, PDA Journal of Pharmaceutical Science and Technology, The EMBO Journal, Biotechnology Progress and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.